Clinical Trial Update: Tocilizumab and Tofacitinib in the Treatment of Vascular Behçet's Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of tocilizumab and tofacitinib for vascular Behçet's syndrome is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Behçet Syndrome Vascular Type

Drugs mentioned

• Tocilizumab (tocilizumab)
• Tofacitinib (tofacitinib)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Aneurysm, Behcet Syndrome, Vascular Type | Phase 2 | Status: RECRUITING